HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of a novel mutation R42P in the gap junction protein beta-3 associated with autosomal dominant erythrokeratoderma variabilis.

Abstract
We report a missense mutation in the gap junction protein beta-3 (encoding Connexin 31), which was detected in only the affected members of a family in which the autosomal dominant skin disease erythrokeratoderma variabilis was segregating. The nucleotide change results in an arginine to proline substitution in codon 42. This residue is positioned on the first transmembrane/first extracellular domain of the gap junction protein with the mutation replacing a negatively charged residue with a nonpolar residue. This change may disrupt the conformation of the protein and voltage gating polarity leading to impaired channel function.
AuthorsA Wilgoss, I M Leigh, M R Barnes, P Dopping-Hepenstal, R A Eady, J M Walter, C T Kennedy, D P Kelsell
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 113 Issue 6 Pg. 1119-22 (Dec 1999) ISSN: 0022-202X [Print] United States
PMID10594760 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Connexins
  • GJB3 protein, human
Topics
  • Connexins (genetics)
  • Dermatitis, Exfoliative (genetics, pathology)
  • Female
  • Humans
  • Ichthyosis (genetics, pathology)
  • Keratosis (genetics, pathology)
  • Male
  • Mutation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: